Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals - BioLegacy Research

Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals

Post author:Sam
Post published:February 2, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace